
Ode Pharma
Bringing a respiratory medicine to Japan
Problem / Difficulty
A long process and a high budget to go the path of licensing a drug in Japan, involving clinical trials in most cases.
Challenge
Choosing the right partner and approach to obtain the necessary approvals in parallel during the pandemic.
Solution
Our research found that the product's ingredients were on the Ministry of Health, Labour and Welfare's safety list. We distributed it as a food additive while proceeding with the pharmaceutical process in parallel, completed the clinical trial, and supported a trial of 180,000 supplement doses (3,000 employees × 60 tablets).





